Financhill
Sell
44

SMMT Quote, Financials, Valuation and Earnings

Last price:
$22.09
Seasonality move :
-4.4%
Day range:
$21.77 - $23.03
52-week range:
$6.78 - $36.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16,804.24x
P/B ratio:
47.62x
Volume:
3.5M
Avg. volume:
4.5M
1-year change:
176.69%
Market cap:
$16.4B
Revenue:
--
EPS (TTM):
-$0.35

Earnings Data

Next earnings date for SMMT
Aug 06
2025
Most recent earnings per share
-$0.09
Beat by $0.00
(May 1/2025)
Consensus Estimate
-$0.09
(May 1/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SMMT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/06/2025 Q2 -- -- -- -$0.09 --
05/01/2025 Q1 -- -- -$0.09 -$0.09 $0.00
02/24/2025 Q4 -- -- -$0.09 -$0.08 -$0.01
10/30/2024 Q3 -- -- -$0.08 -$0.07 -$0.01
08/06/2024 Q2 -- -- -$0.09 -$0.06 -$0.03
05/01/2024 Q1 -- -- -$0.06 -$0.06 -$0.00
02/20/2024 Q4 -- -- -$0.01 -- --
11/07/2023 Q3 -- -- -$0.03 -- --
08/09/2023 Q2 -- -- -$0.02 -- --
05/11/2023 Q1 -- -- -$1.43 -- --
03/09/2023 Q4 -- -- -$0.04 -- --
11/09/2022 Q3 -- -- -$0.14 -- --
08/11/2022 Q2 -- -- -$0.17 -- --
05/11/2022 Q1 -- -- -$0.22 -- --
03/17/2022 Q4 -- -- -$0.28 -- --
11/15/2021 Q3 -- -- -$0.20 -$0.29 $0.09
08/11/2021 Q2 -- -- -$0.27 -$0.18 -$0.09
05/17/2021 Q1 -- -- -$0.21 -$0.17 -$0.04
12/31/2020 Q4 -- -- -$0.18 -$0.21 $0.03
11/16/2020 Q3 -- -- -$0.26 -$0.24 -$0.02
06/30/2020 Q2 -- -- -- -$0.08 --
03/31/2020 Q1 -- -- -$0.01 -$0.02 $0.01
03/27/2020 Q1 -- -- -- -$0.40 --
03/27/2020 Q4 -- -- -- -$0.03 --
12/17/2019 Q4 -- -- -$0.05 -- --
10/11/2019 Q3 -- -- -$0.18 -$0.56 $0.38
06/12/2019 Q2 -- -- -$0.19 -$0.26 $0.06
03/27/2019 Q1 -- -- -$0.33 -- --
12/11/2018 Q4 -- -- -$0.63 -$0.15 -$0.47
09/14/2018 Q3 -- -- $2.43 -$0.39 $2.82
06/05/2018 Q2 -- -- -$0.53 -$0.14 -$0.40
04/11/2018 Q1 -- -- -$1.14 -$0.12 -$1.01
12/06/2017 Q4 -- -- -$0.20 -$0.13 -$0.07
08/31/2017 Q3 -- -- $1.09 $0.32 $0.77
06/14/2017 Q2 -- -- -$0.51 -- --
03/29/2017 Q1 -- -- -$0.50 -- --

Summit Therapeutics Earnings Questions

  • How Much did Summit Therapeutics Generate in Revenue Last Quarter?

    Summit Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Summit Therapeutics Beat Earnings Last Quarter?

    Summit Therapeutics announced earnings per share of -$0.09 which represents a beat of analyst forecast a -$0.09 per share.

  • Is Summit Therapeutics Profitable?

    Summit Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Summit Therapeutics EPS Next Year?

    Summit Therapeutics's earnings are forecast to decrease from -$0.31 per share to -$0.30 per share next year representing a decrease of -29.2%.

  • When is Summit Therapeutics's Earnings Date?

    Summit Therapeutics's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will VICI Properties Be in 5 Years?
Where Will VICI Properties Be in 5 Years?

VICI Properties (NYSE:VICI) is a real estate investment trust focused…

Where Will Exxon Stock Be in 5 Years?
Where Will Exxon Stock Be in 5 Years?

For sure Exxon Mobil (NYSE: XOM) is no hyped-up AI…

How High Will Dollar General Stock Go?
How High Will Dollar General Stock Go?

Shares of Dollar General (NYSE:DG) have risen significantly in recent…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
75
INSM alert for Jun 11

Insmed [INSM] is up 28.58% over the past day.

Sell
25
AAON alert for Jun 11

AAON [AAON] is down 16.44% over the past day.

Buy
58
EXOD alert for Jun 11

Exodus Movement [EXOD] is up 16.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock